Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders
DETQ, an allosteric potentiator of the dopamine D1 receptor, was tested in therapeutic models that were known to respond to D1 agonists. Because of a species difference in affinity for DETQ, all rodent experiments used transgenic mice expressing the human D1 receptor (hD1 mice). When given alone, DE...
Saved in:
Published in | Neuropharmacology Vol. 128; pp. 351 - 365 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!